Results for the Fourth Quarter 2023

Sales ended at MNOK 135.6, 4.4 % below our all-time high Q4 last year (MNOK 141.8). Full year sales revenue is a new record at MNOK 526.4 (MNOK 491.9), up 7.0 %

Currency neutral sales of own products was down 17.4 % for the quarter and down 5.1 % for the year.

Download the full report and presentation, and watch the video recording from the webinar below.

Quarterly Report Q4 2023

Medistim ASA Q4 2023 Presentation